Daniel Geschwind, MD, PhD
Gordon and Virginia MacDonald Distinguished Professor in Neurology, Psychiatry and Human Genetics, Senior Associate Dean and Associate Vice Chancellor for Precision Health, Director, Center for Autism Research and Treatment, Semel Institute, UCLA

Dr. Daniel Geschwind obtained his M.D./Ph.D (neurobiology) at Yale School of Medicine (AOA) and completed his internship, residency (Neurology), and postdoctoral fellowship at UCLA, joining the faculty in 1997. Dr. Geschwind’s laboratory takes a system biology approach, integrating genetic, genomic and bio-informatic approaches with basic neurobiological investigation in model systems and human brain. The over-arching goal of these efforts is to develop new therapeutics for nervous system disorders for which disease-altering therapies are not currently available, including autism and neurodegenerative disorders.

He serves on the editorial boards of several journals including Cell, Current Opinion in Genetics & Development, Neuron and Science and has published over 450 manuscripts. Dr. Geschwind is also a strong advocate for data and biomaterial sharing, having provided scientific oversight for the Autism Genetic Resource Exchange (AGRE), and is an elected member of the American Academy of Physicians and the National Academy of Medicine, USA.